BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25712539)

  • 21. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2.
    Einerson RR; Law ME; Blair HE; Kurtin PJ; McClure RF; Ketterling RP; Flynn HC; Dogan A; Remstein ED
    Leukemia; 2006 Oct; 20(10):1790-9. PubMed ID: 16888615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.
    Haralambieva E; Adam P; Ventura R; Katzenberger T; Kalla J; Höller S; Hartmann M; Rosenwald A; Greiner A; Muller-Hermelink HK; Banham AH; Ott G
    Leukemia; 2006 Jul; 20(7):1300-3. PubMed ID: 16673020
    [No Abstract]   [Full Text] [Related]  

  • 23. Chromosome abnormalities in diffuse large B-cell lymphomas: analysis of 231 Chinese patients.
    Zhao X; Fan R; Lin G; Wang X
    Hematol Oncol; 2013 Sep; 31(3):127-35. PubMed ID: 23135954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation.
    Perkins SL; Pickering D; Lowe EJ; Zwick D; Abromowitch M; Davenport G; Cairo MS; Sanger WG
    Br J Haematol; 2005 Dec; 131(5):624-7. PubMed ID: 16351638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
    Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
    Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic alterations underlying immune privilege in malignant lymphomas.
    Mottok A; Steidl C
    Curr Opin Hematol; 2015 Jul; 22(4):343-54. PubMed ID: 26049756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B.
    Bosga-Bouwer AG; Haralambieva E; Booman M; Boonstra R; van den Berg A; Schuuring E; van den Berg E; Kluin P; Poppema S
    Genes Chromosomes Cancer; 2005 Nov; 44(3):301-4. PubMed ID: 16075463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
    Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the chromosomal translocation t(11;18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B-cell lymphomas of the ocular adnexa: evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin-fixed, paraffin-embedded specimens.
    Takada S; Yoshino T; Taniwaki M; Nakamura N; Nakamine H; Oshima K; Sadahira Y; Inagaki H; Oshima K; Tadaatsu A
    Mod Pathol; 2003 May; 16(5):445-52. PubMed ID: 12748251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma.
    Bosga-Bouwer AG; Kok K; Booman M; Boven L; van der Vlies P; van den Berg A; van den Berg E; de Jong B; Poppema S; Kluin P
    Genes Chromosomes Cancer; 2006 Oct; 45(10):976-81. PubMed ID: 16865685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
    Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
    Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.
    Jordanova ES; Riemersma SA; Philippo K; Giphart-Gassler M; Schuuring E; Kluin PM
    Genes Chromosomes Cancer; 2002 Sep; 35(1):38-48. PubMed ID: 12203788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
    Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C
    Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.
    Streubel B; Vinatzer U; Lamprecht A; Raderer M; Chott A
    Leukemia; 2005 Apr; 19(4):652-8. PubMed ID: 15703784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotype profiling of primary testicular diffuse large B-cell lymphomas.
    Menter T; Ernst M; Drachneris J; Dirnhofer S; Barghorn A; Went P; Tzankov A
    Hematol Oncol; 2014 Jun; 32(2):72-81. PubMed ID: 23949965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large-cell transformation of a composite lymphoma.
    diSibio G; Gabor EP; Lopategui J; Sabath DE; Alsabeh R; Cole JM
    Exp Mol Pathol; 2010 Dec; 89(3):260-7. PubMed ID: 20621095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
    Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
    Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
    van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
    Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.
    Riemersma SA; Jordanova ES; Schop RF; Philippo K; Looijenga LH; Schuuring E; Kluin PM
    Blood; 2000 Nov; 96(10):3569-77. PubMed ID: 11071656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
    Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.